Nature Communications (Dec 2022)

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy

  • Jifeng Yu,
  • Bangguo Zhou,
  • Shen Zhang,
  • Haohao Yin,
  • Liping Sun,
  • Yinying Pu,
  • Boyang Zhou,
  • Yikang Sun,
  • Xiaolong Li,
  • Yan Fang,
  • Lifan Wang,
  • Chongke Zhao,
  • Dou Du,
  • Yan Zhang,
  • Huixiong Xu

DOI
https://doi.org/10.1038/s41467-022-35580-z
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 20

Abstract

Read online

Recently, strategies based on the integration of nanotechnology with microbial carriers have been proposed for cancer therapy. Here the authors report the design of an ultrasound-controlled CRISPR/Cas9 gene editing system for IDO1 silencing compounded with the probiotic Lactobacillus rhamnosus GG, showing the induction of anti-tumor immune responses in preclinical cancer models.